Indian Atorvastatin Exporters: Complete Supplier Ranking with Market Share — 477 Manufacturers (2026) — TransData Nexus

Q: Who is the largest atorvastatin supplier from India?

INTAS PHARMACEUTICALS LIMITED is the largest atorvastatin exporter from India with a 24.6% market share and export value of $265.9M.

Q: How many atorvastatin suppliers are there in India?

There are 477 active atorvastatin exporters in India, collectively shipping $1.1B worth of atorvastatin across 15,000 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top atorvastatin suppliers from India?

The top 5 atorvastatin suppliers from India — INTAS PHARMACEUTICALS LIMITED, PIRAMAL PHARMA LIMITED, MYLAN LABORATORIES LIMITED, MSN LABORATORIES PRIVATE LIMITED, ALKEM LABORATORIES LIMITED — together control 73.2% of total atorvastatin export value from India.

Suresh Sormare

Atorvastatin

India Pharmaceutical Trade Intelligence

$1.1B477 Suppliers145 CountriesHS 30049099

ExportsIndia → UNITED STATES52.5%India → CANADA25.9%

ImportsCROATIA → India$3.5M CANADA → India$2.5M

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: APOTEX CORP

Atorvastatin Suppliers from India (2026) — 477 Exporters, $1.1B Market | TransData Nexus | TransData Nexus

Who Exports Atorvastatin from India — 477 Suppliers Behind a $1.1B Market

India's atorvastatin export market is supplied by 477 active exporters who collectively shipped $1.1B across 15,000 shipments. INTAS PHARMACEUTICALS LIMITED leads with a 24.6% market share, followed by PIRAMAL PHARMA LIMITED and MYLAN LABORATORIES LIMITED. The top 5 suppliers together control 73.2% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published May 2026

India's Top Atorvastatin Suppliers & Exporters — 477 manufacturers, $1.1B export market, top destinations and formulations — Atorvastatin supplier data — 477 exporters · $1.1B market · 15,000 shipmentsTransData Nexus · Indian Customs Data

Top Atorvastatin Exporters from India — Ranked by Export Value

INTAS PHARMACEUTICALS LIMITED is the leading atorvastatin exporter from India, holding a 24.6% share of the $1.1B market across 15,000 shipments from 477 exporters. The top 5 suppliers — INTAS PHARMACEUTICALS LIMITED, PIRAMAL PHARMA LIMITED, MYLAN LABORATORIES LIMITED, MSN LABORATORIES PRIVATE LIMITED, ALKEM LABORATORIES LIMITED — collectively control 73.2% of total export value, indicating a highly concentrated market. Individual shares are: INTAS PHARMACEUTICALS LIMITED (24.6%), PIRAMAL PHARMA LIMITED (22.4%), MYLAN LABORATORIES LIMITED (14.6%), MSN LABORATORIES PRIVATE LIMITED (7.7%), ALKEM LABORATORIES LIMITED (3.8%).

Top Atorvastatin Exporters from India

Ranked by export value · 477 active suppliers · Indian Customs (DGFT) data

May 2026

Top Atorvastatin Exporters from India — Ranked by Export Value. 477 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Atorvastatin — Export Intelligence Video

Visual overview of India's atorvastatin supplier landscape — top suppliers, destinations, pricing, and trade routes

This video covers India's atorvastatin pharmaceutical supplier landscape — $1.1B in total trade, 477 verified manufacturers. Data sourced from Indian Customs (DGFT) shipment records.

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Atorvastatin exporters

Certification and compliance status for top Atorvastatin suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
Intas Pharmaceuticals Limited	Warning Letter, December	Yes, April 2007	Yes	Not verified	Received EU GMP certification in April 2007; FDA issued a warning letter in Dece
Mylan Laboratories Limited	Approved	Yes	Yes	Multiple	Holds multiple FDA approvals and WHO GMP certification; no FDA warning letters r
MSN Laboratories Private Limited	Approved	Yes	Yes	Multiple	Holds multiple FDA approvals and WHO GMP certification; no FDA warning letters r
Sun Pharmaceutical Industries Limited	Approved	Yes	Yes	Multiple	Holds multiple FDA approvals and WHO GMP certification; no FDA warning letters r
Aurobindo Pharma Ltd	Approved	Yes	Yes	Multiple	Holds multiple FDA approvals and WHO GMP certification; no FDA warning letters r
Alkem Laboratories Limited	Approved	Yes	Yes	Multiple	Holds multiple FDA approvals and WHO GMP certification; no FDA warning letters r
Biocon Pharma Limited	Approved	Yes	Yes	Multiple	Holds multiple FDA approvals and WHO GMP certification; no FDA warning letters r
Jubilant Generics Limited	Approved	Yes	Yes	Multiple	Holds multiple FDA approvals and WHO GMP certification; no FDA warning letters r
Apotex Research Private Limited	Approved	Yes	Yes	Multiple	Holds multiple FDA approvals and WHO GMP certification; no FDA warning letters r

TransData Nexus reviewed the regulatory standing of 9 leading Atorvastatin exporters from India. 8 hold US FDA facility approvals, 9 maintain WHO-GMP certification, and 9 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Atorvastatin sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes over 40% of the country's bulk drug production. The city hosts numerous Active Pharmaceutical Ingredient (API) manufacturers, including companies like SVK Laboratories Private Limited, which specializes in bulk drugs and intermediates. This concentration of API producers makes Hyderabad a pivotal hub for sourcing raw materials essential for Atorvastatin production.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations. This region houses major companies like Alembic Pharmaceuticals, which specializes in formulations for therapeutic areas such as cardiology. The presence of such companies underscores the region's capacity in producing finished pharmaceutical products, including Atorvastatin formulations.

3Mumbai-Thane-Raigad — Export Gateway

The Mumbai-Thane-Raigad belt serves as a critical export gateway for pharmaceutical products. Its proximity to major ports facilitates efficient international distribution. Companies in this region benefit from well-established logistics and regulatory frameworks, enhancing their ability to export Atorvastatin to key markets such as the United States and Canada.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Atorvastatin exporters from India

March 2021

M&A

Piramal Pharma Limited — Piramal Pharma acquires peptide API-maker Hemmo Pharmaceuticals

Piramal Pharma Solutions, a division of Piramal Pharma Limited, completed the acquisition of Hemmo Pharmaceuticals, a leading manufacturer of peptide active pharmaceutical ingredients (APIs). This strategic move aims to enhance Piramal's capabilities in the peptide API segment. - IMPACT: The acquisition is expected to strengthen Piramal Pharma's position in the API market, potentially increasing its Atorvastatin export capacity.

Impact: The acquisition is expected to strengthen Piramal Pharma's position in the API market, potentially increasing its Atorvastatin export capacity.

August 2022

M&A

Piramal Pharma Limited — Piramal Pharma completes full acquisition of Convergence Chemicals

Piramal Pharma Limited completed the acquisition of Convergence Chemicals, aiming to bolster its manufacturing capabilities and expand its product portfolio. - IMPACT: This acquisition may enhance Piramal Pharma's production capacity, potentially impacting its Atorvastatin exports.

Impact: This acquisition may enhance Piramal Pharma's production capacity, potentially impacting its Atorvastatin exports.

Common Questions — Atorvastatin Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which atorvastatin supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, INTAS PHARMACEUTICALS LIMITED leads with 328 recorded shipments worth $265.9M. PIRAMAL PHARMA LIMITED (429 shipments) and MYLAN LABORATORIES LIMITED (330 shipments) are also established high-volume exporters.

Q How many atorvastatin manufacturers are there in India?

India has 477 active atorvastatin exporters with a combined export market of $1.1B across 15,000 shipments to 145 countries. The top 5 suppliers hold 73.2% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for atorvastatin from India?

Average FOB unit price: $6.13 per unit, ranging from $0.00 to $5113.40. Average shipment value: $72.0K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Atorvastatin

Atorvastatin

Who Exports Atorvastatin from India — 477 Suppliers Behind a $1.1B Market

Top Atorvastatin Exporters from India — Ranked by Export Value

Top Atorvastatin Exporters from India

Related Analysis

Need Details?

Atorvastatin — Export Intelligence Video

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Piramal Pharma Limited — Piramal Pharma acquires peptide API-maker Hemmo Pharmaceuticals

Piramal Pharma Limited — Piramal Pharma completes full acquisition of Convergence Chemicals

Common Questions — Atorvastatin Suppliers from India

Q Which atorvastatin supplier from India is the most reliable for bulk orders?

Q How many atorvastatin manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for atorvastatin from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Amneal Pharmaceuticals — Amneal Pharmaceuticals acquires Punishka Healthcare

Analysis Methodology